166 related articles for article (PubMed ID: 34020765)
41. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges.
Patel DN; Li L; Kee CL; Ge X; Low MY; Koh HL
J Pharm Biomed Anal; 2014 Jan; 87():176-90. PubMed ID: 23721687
[TBL] [Abstract][Full Text] [Related]
42. High-Dimensional Single-Cell Analysis with Mass Cytometry.
Brodie TM; Tosevski V
Curr Protoc Immunol; 2017 Aug; 118():5.11.1-5.11.25. PubMed ID: 28762483
[TBL] [Abstract][Full Text] [Related]
43. Broad Immune Monitoring and Profiling of T Cell Subsets with Mass Cytometry.
Brodie TM; Tosevski V
Methods Mol Biol; 2018; 1745():67-82. PubMed ID: 29476463
[TBL] [Abstract][Full Text] [Related]
44. A practical guide to multiplexed mass cytometry.
Zivanovic N; Jacobs A; Bodenmiller B
Curr Top Microbiol Immunol; 2014; 377():95-109. PubMed ID: 23918170
[TBL] [Abstract][Full Text] [Related]
45. Imaging mass cytometry: High-dimensional and single-cell perspectives on the microenvironment of solid tumours.
Liu Z; Xun J; Liu S; Wang B; Zhang A; Zhang L; Wang X; Zhang Q
Prog Biophys Mol Biol; 2022 Nov; 175():140-146. PubMed ID: 36252872
[TBL] [Abstract][Full Text] [Related]
46. Mass Spectrometry Imaging and Integration with Other Imaging Modalities for Greater Molecular Understanding of Biological Tissues.
Porta Siegel T; Hamm G; Bunch J; Cappell J; Fletcher JS; Schwamborn K
Mol Imaging Biol; 2018 Dec; 20(6):888-901. PubMed ID: 30167993
[TBL] [Abstract][Full Text] [Related]
47. Applying Mass Cytometry to the Analysis of Lymphoid Populations in Transplantation.
Krams SM; Schaffert S; Lau AH; Martinez OM
Am J Transplant; 2017 Aug; 17(8):1992-1999. PubMed ID: 27888565
[TBL] [Abstract][Full Text] [Related]
48. Simultaneous Detection of Protein and mRNA in Jurkat and KG-1a Cells by Mass Cytometry.
Mavropoulos A; Allo B; He M; Park E; Majonis D; Ornatsky O
Cytometry A; 2017 Dec; 91(12):1200-1208. PubMed ID: 29194963
[TBL] [Abstract][Full Text] [Related]
49. Dual-labelled antibodies for flow and mass cytometry: A new tool for cross-platform comparison and enrichment of target cells for mass cytometry.
Baumgart S; Schulz AR; Peddinghaus A; Stanislawiak S; Gillert S; Hirseland H; Krauthäuser S; Dose C; Mei HE; Grützkau A
Eur J Immunol; 2017 Aug; 47(8):1377-1385. PubMed ID: 28654217
[TBL] [Abstract][Full Text] [Related]
50. Compensation of Signal Spillover in Suspension and Imaging Mass Cytometry.
Chevrier S; Crowell HL; Zanotelli VRT; Engler S; Robinson MD; Bodenmiller B
Cell Syst; 2018 May; 6(5):612-620.e5. PubMed ID: 29605184
[TBL] [Abstract][Full Text] [Related]
51. Using Imaging Mass Cytometry to Define Cell Identities and Interactions in Human Tissues.
Kakade VR; Weiss M; Cantley LG
Front Physiol; 2021; 12():817181. PubMed ID: 35002783
[TBL] [Abstract][Full Text] [Related]
52. New tools for pathology: a user's review of a highly multiplexed method for in situ analysis of protein and RNA expression in tissue.
Decalf J; Albert ML; Ziai J
J Pathol; 2019 Apr; 247(5):650-661. PubMed ID: 30570141
[TBL] [Abstract][Full Text] [Related]
53. Methods for analyzing tellurium imaging mass cytometry data.
Bassan J; Nitz M
PLoS One; 2019; 14(9):e0221714. PubMed ID: 31479470
[TBL] [Abstract][Full Text] [Related]
54. Staining of Frozen and Formalin-Fixed, Paraffin-Embedded Tissues with Metal-Labeled Antibodies for Imaging Mass Cytometry Analysis.
Chang Q; Ornatsky O; Hedley D
Curr Protoc Cytom; 2017 Oct; 82():12.47.1-12.47.8. PubMed ID: 28967989
[TBL] [Abstract][Full Text] [Related]
55. Unlabeled Competitor Antibody to Reduce Nonlinear Signal Spillover in Mass Cytometry.
Sekhri P; Kim MY; Behbehani GK
Cytometry A; 2019 Aug; 95(8):898-909. PubMed ID: 31120628
[TBL] [Abstract][Full Text] [Related]
56. Hybrid Imaging Labels: Providing the Link Between Mass Spectrometry-Based Molecular Pathology and Theranostics.
Buckle T; van der Wal S; van Malderen SJ; Müller L; Kuil J; van Unen V; Peters RJ; van Bemmel ME; McDonnell LA; Velders AH; Koning F; Vanhaeke F; van Leeuwen FW
Theranostics; 2017; 7(3):624-633. PubMed ID: 28255355
[TBL] [Abstract][Full Text] [Related]
57. Introduction A: recent advances in cytometry instrumentation, probes, and methods--review.
Pierzchalski A; Mittag A; Tárnok A
Methods Cell Biol; 2011; 102():1-21. PubMed ID: 21704833
[TBL] [Abstract][Full Text] [Related]
58. Imaging Mass Cytometry: A promising multiplex detection tool for plant science research.
Leroux O; Closson T; Van Der Straeten D
Mol Plant; 2021 Aug; 14(8):1241-1243. PubMed ID: 34116222
[No Abstract] [Full Text] [Related]
59. Structurally selective imaging mass spectrometry by imaging ion mobility-mass spectrometry.
McLean JA; Fenn LS; Enders JR
Methods Mol Biol; 2010; 656():363-83. PubMed ID: 20680602
[TBL] [Abstract][Full Text] [Related]
60. Multiplex Protein Imaging with Secondary Ion Mass Spectrometry Using Metal Oxide Nanoparticle-Conjugated Antibodies.
Moon DW; Park YH; Lee SY; Lim H; Kwak S; Kim MS; Kim H; Kim E; Jung Y; Hoe HS; Kim S; Lim DK; Kim CH; In SI
ACS Appl Mater Interfaces; 2020 Apr; 12(15):18056-18064. PubMed ID: 32073828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
